Tag Archives: adds

FDA moving to 'risk-based' inspections even as valsartan scare adds new wrinkle to oversight

FDA inspections of generic drug plants are on the rise and should continue to increase through 2019, Commissioner Scott Gottlieb said this week in a series of tweets.  But the game has changed, Gottlieb pointed out, with the number of pre-approval inspections growing more than surveillance inspections, in part to approve more generics in an effort… Read More »

Intelerad adds Clario to support efficient radiologist workflows

Intelerad Medical Systems is acquiring Clario Medical with intentions of offering providers interoperable medical diagnostic solutions. The companies announced the acquisition on Sunday, in advance of the annual meeting of the Radiological Society of North America in Chicago. Terms of the deal were not disclosed. Intelerad develops enterprise workflow solutions, while Clario is a “zero… Read More »